Skip to main content

8-K

Pulmatrix, Inc. (PULM)

8-K 2021-06-17 For: 2021-06-17
View Original
Added on April 08, 2026


UNITEDSTATES

SECURITIESAND EXCHANGE COMMISSION

WASHINGTON,D.C. 20549



FORM8-K



CURRENTREPORT

Pursuantto Section 13 or 15(d) of the

SecuritiesExchange Act of 1934


Dateof Report (Date of earliest event reported): June 17, 2021



PULMATRIX,INC.

(Exactname of registrant as specified in its charter)



Delaware 001-36199 46-1821392
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

99Hayden Avenue, Suite 390

Lexington,MA 02421

(Addressof principal executive offices) (Zip Code)

(781)357-2333

(Registrant’stelephone number, including area code)

N/A

(Formername or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[<br>  ] Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[<br>  ] Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[<br>  ] Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[<br>  ] Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title<br> of each class Trading<br> Symbol(s) Name<br> of exchange on which registered
Common<br> Stock, par value $0.0001 per share PULM The<br> NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]


Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 17, 2021, Pulmatrix, Inc. (the “Company”) held its 2021 annual meeting of stockholders (the “Annual Meeting”). A total of 31,388,300 shares of the Company’s common stock were present in person or represented by proxy at the Annual Meeting. Holders of the Company’s common stock were entitled to one vote per share. The matters submitted for a vote and the related results are set forth below.

(1) Election<br> of two directors to serve as Class I directors on our Board of Directors to serve until our 2024 Annual Meeting of Stockholders or<br> until successors have been duly elected and qualified:
Director For Against Withheld /Abstained Broker Non-Votes
--- --- --- --- --- --- --- --- ---
Todd Bazemore 17,811,322 0 933,563 12,643,414
Christopher Cabell, M.D. 16,146,004 0 2,598,881 12,643,414
(2) Ratification<br> of the appointment of Marcum LLP as our independent registered public accounting firm for the 2021 fiscal year:
--- ---
For Against Withheld /Abstained Broker Non-Votes
--- --- --- ---
29,996,931 365,385 1,025,983 0

For more information about the foregoing proposals, see the Company’s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April 29, 2021, the relevant portions of which are incorporated herein by reference.

The results reported above are final voting results. No other matters were considered or voted upon at the meeting.

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PULMATRIX, INC.
Date:<br> June 17, 2021 By: /s/ Teofilo Raad
Teofilo<br> Raad
Chief<br> Executive Officer